AAIC: Proving drugs modify Alzheimer’s disease faces skepticism
WASHINGTON – Proving disease modification of Alzheimer’s disease in a clinical drug trial may not be easy. Some researchers developing drugs for treating Alzheimer’s disease hope to find a way to...